References
- Klassen AC, Berman ME. Medical care for headache: a consumer survey. (Abstr) Cephalalgia 1991: 11 (Suppl 11): 85–6
- Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988: 8(Suppl 7): 1–96
- Diamond S, Dalessio DJ. Drug abuse in headache. In: Diamond S, Dalessio DJ, eds. The practicing physicians approach to headache. 3d ed. Baltimore: Williams & Wilkins, 1982: 42–58, 114–21
- Packard RC. What does the headache patient want? Headache 1979: 19(7): 370–4
- Wilkinson M. Treatment of migraine. Headache 1988: 28(10): 659–61
- Silberstein SD. Treatment of headache in primary care practice. Am J Med 1984: 77(3A): 65–72
- Mathew NT. Abortive versus prophylactic treatment of migraine: a reappraisal. (Editorial) Headache 1990: 30(4): 238–9
- Raskin NH. Headache. 2d ed. New York: Churchill Livingstone, 1988: 155–64
- Silberstein SD, Silberstein MM. New concepts in the pathogenesis of headache. 1. Migraine versus tension-type headache. Pain Management 1990: 3(Sep-C)ct): 297–303, 334–42
- Silberstein SD. Twenty questions about headaches in children and adolescents. Headache 1990: 30(11): 716–24
- Yuill GM, Swinburn WR, Liversedge LA. A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine. Br J Clin Pract 1972: 26(2): 76–9
- Insel PA. Analgesics-antipyretics and antiinflammatory agents: drugs employed in the treatment of rheumatoid arthritis and gout. In: Gilman AG, Rail TW, Nies AS, et al, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. Elmsford, NY: Pergamon Press, 1990: 638–71
- Sjaastad O, Spierings EL. “Hemicrania continua”: another headache absolutely responsive to indomethacin. Cephalalgia 1984: 4(1): 65–70
- Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991: 114(4): 257–63
- Ziegler DK. The treatment of migraine. In: Dalessio DJ, ed. Wolffs headache and other head pain. 5th ed. New York: Oxford Univ Press, 1987: 87–111
- Berde B, Stürmer E. Introduction to the pharmacology of ergot alkaloids and related compounds as a basis of their therapeutic application. In: Berde B, Schild HO, eds. Handbook of experimental pharmacology. 49. Ergot alkaloids and related compounds. New York: Springer-Verlag, 1978: 1–28
- Peroutka SJ. Developments in 5-hydroxytryptamine receptor pharmacology in migraine. Neurol Clin 1990: 8(4): 829–39
- Sanders SW, Haering N, Mosberg H, et al. Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing. Eur J Clin Pharmacol 1986: 30(3): 331–4
- Kanto J, Allonen H, Koski K, et al. Pharmacokinetics of dihydroergotamine in healthy volunteers and in neurological patients after a single intravenous injection. Int J Clin Pharmacol Ther Toxicol 1981: 19(3): 127–30
- Hilke H, Kanto J, Kleimola T, et al. Intramuscular absorption of dihydroergotamine in man. Int J Clin Pharmacol Biopharm 1978: 16(6): 277–8
- Cady RK, Wendt JK, Kirchner JR, et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991: 265(21): 2831–5
- Volans GN. Research review: migraine and drug absorption. Clin Pharmacokinet 1978: 3(4): 313–8
- Albibi R, McCallum KW. Metoclopramide: pharmacology and clinical application. Ann Intern Med 1983: 98(1): 86–95
- Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987: 27(2): 102–6
- Saper JR. Ergotamine dependency: a review. Headache 1987: 27(8): 435–8
- Scholz E, Diener HC, Geiselhart S. Drug-induced headache: does a critical dosage exist? In: Diener HC, Wilkinson M, eds. Advances in applied neurological sciences. 5. Drug-induced headache. New York: Springer-Verlag, 1988: 29–43